Progyny Total Long Term Liabilities 2018-2024 | PGNY
Progyny total long term liabilities from 2018 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
| Progyny Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $16 |
| 2023 | $17 |
| 2022 | $6 |
| 2021 | $7 |
| 2020 | $9 |
| 2019 | $0 |
| 2018 | $106 |
| 2017 | $115 |
| Progyny Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $16 |
| 2024-09-30 | $17 |
| 2024-06-30 | $17 |
| 2024-03-31 | $17 |
| 2023-12-31 | $17 |
| 2023-09-30 | $18 |
| 2023-06-30 | $18 |
| 2023-03-31 | $18 |
| 2022-12-31 | $6 |
| 2022-09-30 | $7 |
| 2022-06-30 | $7 |
| 2022-03-31 | $7 |
| 2021-12-31 | $7 |
| 2021-09-30 | $8 |
| 2021-06-30 | $9 |
| 2021-03-31 | $9 |
| 2020-12-31 | $9 |
| 2020-09-30 | $1 |
| 2020-06-30 | $0 |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | $106 |
| 2019-06-30 | $106 |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2017-12-31 | $115 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.001B | $1.167B |
| Progyny Inc. is a fertility benefits management company. It specializes in fertility and family building benefits solutions. Progyny Inc. is based in New York, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.013B | 25.51 |
| Elevance Health (ELV) | United States | $93.532B | 12.07 |
| CVS Health (CVS) | United States | $83.782B | 10.41 |
| Cencora (COR) | United States | $56.393B | 20.47 |
| Natera (NTRA) | United States | $21.021B | 0.00 |
| DiDi Global (DIDIY) | China | $20.473B | 31.07 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.189B | 0.00 |
| CochLear (CHEOY) | Australia | $11.336B | 0.00 |
| Solventum (SOLV) | United States | $11.327B | 10.56 |
| ICON (ICLR) | Ireland | $10.910B | 10.14 |
| Revvity (RVTY) | United States | $10.864B | 18.34 |
| Doximity (DOCS) | United States | $10.660B | 55.44 |
| Viatris (VTRS) | United States | $10.056B | 3.20 |
| Medpace Holdings (MEDP) | United States | $8.300B | 22.04 |
| Avantor (AVTR) | United States | $8.164B | 11.86 |
| Sonic Healthcare (SKHHY) | Australia | $8.076B | 0.00 |
| HealthEquity (HQY) | United States | $7.797B | 38.36 |
| Charles River Laboratories (CRL) | United States | $5.668B | 11.18 |
| Amplifon S.p.A (AMFPF) | Italy | $4.736B | 25.00 |
| Bausch + Lomb (BLCO) | Canada | $3.852B | 22.71 |
| BrightSpring Health Services (BTSG) | United States | $3.804B | 35.21 |
| Sotera Health (SHC) | United States | $3.648B | 20.73 |
| Alignment Healthcare (ALHC) | United States | $3.110B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.950B | 33.84 |
| Concentras Parent (CON) | United States | $2.781B | 14.47 |
| Organon (OGN) | United States | $2.373B | 2.52 |
| Premier (PINC) | United States | $2.095B | 14.34 |
| Ardent Health Partners (ARDT) | United States | $1.857B | 7.93 |
| Agilon Health (AGL) | United States | $1.842B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.776B | 69.53 |
| GoodRx Holdings (GDRX) | United States | $1.634B | 35.50 |
| PACS (PACS) | United States | $1.503B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.243B | 9.46 |
| Teladoc Health (TDOC) | United States | $1.189B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.952B | 0.00 | |
| CareDx (CDNA) | United States | $0.790B | 12.33 |
| AMN Healthcare Services Inc (AMN) | United States | $0.748B | 5.92 |
| Nutex Health (NUTX) | United States | $0.735B | 14.39 |
| Embecta (EMBC) | United States | $0.710B | 4.86 |
| QDM (QDMI) | Hong Kong, SAR China | $0.671B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.518B | 13.73 |
| Sonida Senior Living (SNDA) | United States | $0.440B | 0.00 |
| Enhabit (EHAB) | United States | $0.407B | 38.29 |
| InnovAge Holding (INNV) | United States | $0.385B | 0.00 |
| LifeMD (LFMD) | United States | $0.341B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.338B | 0.00 |
| SBC Medicals (SBC) | United States | $0.323B | 0.00 |
| DocGo (DCGO) | United States | $0.239B | 9.75 |
| Oncology Institute (TOI) | United States | $0.197B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.177B | 0.00 |
| Beauty Health (SKIN) | United States | $0.132B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.095B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.089B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| OncoCyte (OCX) | United States | $0.083B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| ModivCare (MODV) | United States | $0.020B | 7.10 |
| KindlyMD (KDLY) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |